Studies Conducted at University of Manchester on Sensorineural Hearing Loss Recently Published (A national survey of first line antibiotic use in neonatal units - and the potential scope for iatrogenic sensorineural hearing loss prevention).

A recent study conducted at the University of Manchester focused on the potential prevention of iatrogenic sensorineural hearing loss in neonatal units due to aminoglycoside exposure. The study found that most neonatal units in the UK use aminoglycosides as first-line antibiotic agents, putting infants with a specific genetic variant at risk. The researchers suggest integrating point-of-care genetic testing into neonatal septic screening pathways to address this issue. For more information, the full article can be accessed through Frontiers in Pediatrics. [Extracted from the article]